Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.
Bi N, Liu L, Liang J, Wu S, Chen M, Lv C, Zhao L, Shi A, Jiang W, Xu Y, Zhou Z, Wang J, Wang W, Chen D, Hui Z, Lv J, Zhang H, Feng Q, Xiao Z, Wang X, Zhang T, Yin W, Li J, He J, Wang L.
Bi N, et al. Among authors: yin w.
BMC Cancer. 2020 Apr 6;20(1):278. doi: 10.1186/s12885-020-06780-x.
BMC Cancer. 2020.
PMID: 32252680
Free PMC article.